Status:
UNKNOWN
GWAS in NMDAR Encephalitis
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Autoimmune Encephalitis
Eligibility:
All Genders
Brief Summary
Autoimmune encephalitis are characterized by the subacute development of memory deficits, altered mental status, and psychiatric symptoms, generally in association with anti-neuronal antibodies. Two m...
Eligibility Criteria
Inclusion
- Presence of well-characterized antibodies in serum or cerebrospinal fluid;
- Clinical picture compatible with the detected antibody based on the literature
Exclusion
- Absence of complete clinicobiological data.
- Alternative diagnosis
Key Trial Info
Start Date :
December 15 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT05225883
Start Date
December 15 2020
End Date
December 1 2025
Last Update
February 7 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre de référence des syndromes neurologiques paranéoplasiques et encéphalites auto-immunes
Lyon, France